Lymphangiogenesis and lung cancer

Journal of Thoracic Oncology

Volumn 2, Issue 5, 2007, Pages 384-386

  Rouzaut, Ana ^a,b   Irigoyen, Marta ^a,b   Montuenga, Luis M ^a,b  

^a UNIVERSITY OF NAVARRA   (Spain)

^b UNIVERSITY OF NAVARRA   (Spain)

Author keywords

[No Author keywords available]

Indexed keywords

5,6,7,13 TETRAHYDRO 12 (3 HYDROXYPROPYL) 9 ISOPROPOXYMETHYLINDENO[2,1 A]PYRROLO[3,4 C]CARBAZOL 5(12H) ONE DIMETHYLGLYCINE ESTER; ALPHA INTEGRIN; ANGIOPOIETIN; BETA1 INTEGRIN; FIBROBLAST GROWTH FACTOR 2; KETONE DERIVATIVE; MAE 87; MAZ 51; NEUROPILIN 2; PLATELET DERIVED GROWTH FACTOR B; PODOPLANIN; PROTEIN LYVE 1; RECEPTOR; SCATTER FACTOR; SORAFENIB; UNCLASSIFIED DRUG; VASCULOTROPIN C; VASCULOTROPIN D; VASCULOTROPIN RECEPTOR 2; VASCULOTROPIN RECEPTOR 3; VATALANIB; ANGIOGENESIS INHIBITOR; PROTEIN KINASE INHIBITOR; VASCULOTROPIN; VASCULOTROPIN RECEPTOR;

CANCER CELL; EDEMA; HEMATOPOIESIS; HUMAN; IMMUNOHISTOCHEMISTRY; LUNG CANCER; LYMPH NODE; LYMPHANGIOGENESIS; LYMPHATIC SYSTEM; NONHUMAN; PRIORITY JOURNAL; PROTEIN ANALYSIS; PROTEIN DETERMINATION; PROTEIN FUNCTION; PROTEIN SECRETION; REGULATORY MECHANISM; SHORT SURVEY; VASCULARIZATION; ANIMAL; CANCER STAGING; DRUG ANTAGONISM; LUNG TUMOR; LYMPH NODE METASTASIS; METABOLISM; NEOVASCULARIZATION (PATHOLOGY); PATHOLOGY; REVIEW;

ANGIOGENESIS INHIBITORS; ANIMALS; HUMANS; LUNG NEOPLASMS; LYMPHANGIOGENESIS; LYMPHATIC METASTASIS; NEOPLASM STAGING; NEOVASCULARIZATION, PATHOLOGIC; PROTEIN KINASE INHIBITORS; RECEPTORS, VASCULAR ENDOTHELIAL GROWTH FACTOR; VASCULAR ENDOTHELIAL GROWTH FACTORS;

EID: 34249860712     PISSN: 15560864     EISSN: 15561380     Source Type: Journal    
DOI: 10.1097/01.JTO.0000268670.72249.ad     Document Type: Article

References (22)

1. Saharinen P, Tammela T, Karkkainen MJ, Alitalo K. Lymphatic vasculature: development, molecular regulation and role in tumor metastasis and inflammation Trends Immunol 2004;25:387-395.
2. Tobler NE, Detmar M. Tumor and lymph node lymphangiogenesis: impact on cancer metastasis. J Leukoc Biol 2006;80:691-696.
3. Alitalo K, Tammela T, Petrova TV. Lymphangiogenesis in development and human disease. Nature 2005;438:946-953.
4. Folkman J. Angiogenesis. Annu Rev Med 2006;57:1-18.
5. Van der Auwera I, Cao Y, Tille JC, et al First international consensus on the methodology of lymphangiogenesis quantification in solid human tumours. Br J Cancer 2006;95:1611-1625.
6. Kaipainen A, Korhonen J, Mustonen T, et al Expression of the fms-like tyrosine kinase 4 gene becomes restricted to lymphatic endothelium during development. Proc Natl Acad Sci USA 1995;92:3566-3570.
7. Wissmann C, Detmar M. Pathways targeting tumor lymphangiogenesis. Clin Cancer Res 2006;12:6865-6868.
8. Yuan L, Moyon D, Pardanaud L, et al Abnormal lymphatic vessel development in neuropilin 2 mutant mice. Development 2002;129:4797-4806.
9. Vlahakis NE, Young BA, Atakilit A, Sheppard D. The lymphangiogenic vascular endothelial growth factors VEGF-C and -D are ligands for the integrin alpha9beta1. J Biol Chem 2005;280:4544-4552.
10. Hirakawa S, Kodama S, Kunstfeld R, Kajiya K, Brown LF, Detmar M. VEGF-A induces tumor and sentinel lymph node lymphangiogenesis and promotes lymphatic metastasis. J Exp Med 2005;201:1089-1099.
11. Cueni LN, Detmar M. New insights into the molecular control of the lymphatic vascular system and its role in disease. J Invest Dermatol 2006;126:2167-2177.
12. Su JL, Yang PC, Shih JY, et al The VEGF-C/Flt-4 axis promotes invasion and metastasis of cancer cells. Cancer Cell 2006;9:209-223.
13. Padera TP, Kadambi A, di Tomaso E, et al Lymphatic metastasis in the absence of functional intratumor lymphatics. Science 2002;296:1883-1886.
14. Ji RC. Lymphatic endothelial cells, tumor lymphangiogenesis and metastasis: new insights into intratumoral and peritumoral lymphatics. Cancer Metast Rev 2006;25:677-694.
15. Itoh H, Nakatsu M, Yoxtheimer LM, Uematsu H, Ohno Y, Hatabu H. Structural basis for pulmonary functional imaging. Eur J Radiol 2001;37:143-154.
16. Tanno S, Ohsaki Y, Nakanishi K, Toyoshima E, Kikuchi K. Human small cell lung cancer cells express functional VEGF receptors, VEGFR-2 and VEGFR-3. Lung Cancer 2004;46:11-19.
17. Renyi-Vamos F, Tovari J, Fillinger J, et al Lymphangiogenesis correlates with lymph node metastasis, prognosis, and angiogenic phenotype in human non-small cell lung cancer. Clin Cancer Res 2005;11:7344-7353.
18. Tamura M, Oda M, Tsunezuka Y, et al Chest CT and serum vascular endothelial growth factor-C level to diagnose lymph node metastasis in patients with primary non-small cell lung cancer. Chest 2004;126:342-346.
19. Koukourakis MI, Giatromanolaki A, Sivridis E, et al LYVE-1 immuno-histochemical assessment of lymphangiogenesis in endometrial and lung cancer. J Clin Pathol 2005;58:202-206.
20. Wissmann C, Detmar M. Pathways targeting tumor lymphangiogenesis. Clin Cancer Res 2006;12:6865-6868.
21. He Y, Kozaki K, Karpanen T, et al Suppression of tumor lymphangiogenesis and lymph node metastasis by blocking vascular endothelial growth factor receptor 3 signaling. J Natl Cancer Inst 2002;94:819-825.
22. Achen MG, McColl BK, Stacker SA. Focus on lymphangiogenesis in tumor metastasis. Cancer Cell 2005;7:121-127.